Immediate Impact
26 standout
Citing Papers
Present and future of cancer nano-immunotherapy: opportunities, obstacles and challenges
2025 Standout
Biodegradable and Stimuli-Responsive Nanomaterials for Targeted Drug Delivery in Autoimmune Diseases
2025 Standout
Works of Sofía del Carmen being referenced
Value of PD-L1, PD-1, and CTLA-4 Expression in the Clinical Practice as Predictors of Response to Nivolumab and Ipilimumab in Monotherapy in Patients With Advanced Stage Melanoma
2020
Causes of hOCT1‐Dependent Cholangiocarcinoma Resistance to Sorafenib and Sensitization by Tumor‐Selective Gene Therapy
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Sofía del Carmen | 120 | 47 | 59 | 87 | 86 | 22 | 238 | |
| Shi‐Xun Lu | 110 | 31 | 48 | 96 | 60 | 21 | 247 | |
| Phillipe Taniere | 109 | 37 | 63 | 94 | 60 | 23 | 263 | |
| Miho Okano | 137 | 26 | 48 | 134 | 87 | 24 | 274 | |
| Vincenzo Famiglietti | 214 | 48 | 44 | 55 | 59 | 27 | 273 | |
| Nebojša Manojlović | 211 | 42 | 41 | 57 | 54 | 24 | 269 | |
| Akira Okimura | 136 | 27 | 65 | 112 | 49 | 26 | 284 | |
| Zu‐Lu Ye | 111 | 71 | 28 | 112 | 84 | 24 | 271 | |
| Xiaoqing Xu | 122 | 28 | 53 | 98 | 94 | 26 | 286 | |
| Shota Fujimoto | 141 | 47 | 64 | 89 | 47 | 25 | 293 | |
| Laura Matteucci | 134 | 56 | 58 | 68 | 76 | 15 | 258 |
All Works
Login with ORCID to disown or claim papers
Loading papers...